메뉴 건너뛰기




Volumn 14, Issue 2, 2003, Pages 277-281

Early cardiotoxicity of the CHOP regimen in aggreessive non-Hodgkin's lymphoma

Author keywords

Cardioprotection; Cardiotoxicity; Congestive heart failure; Doxorubicin; Non Hodgkin's

Indexed keywords

CYCLOPHOSPHAMIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RAZOXANE; VINCRISTINE; VINDESINE;

EID: 0037293503     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg070     Document Type: Article
Times cited : (123)

References (30)
  • 1
    • 0018716636 scopus 로고
    • Risk factors for doxorubicin-induced congestive heart failure
    • Von Hoff D, Layard M, Basa P et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91: 710-717.
    • (1979) Ann. Intern. Med. , vol.91 , pp. 710-717
    • Von Hoff, D.1    Layard, M.2    Basa, P.3
  • 3
    • 0032563825 scopus 로고    scopus 로고
    • Current concepts: Doxorubicin-induced cardiomyopathy
    • Singal P, Iliskovic N. Current concepts: doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905.
    • (1998) N. Engl. J. Med. , vol.339 , pp. 900-905
    • Singal, P.1    Iliskovic, N.2
  • 4
    • 0031852560 scopus 로고    scopus 로고
    • Anthracycline cardiotoxicity, no longer an issue?
    • Green M. Anthracycline cardiotoxicity, no longer an issue? Ann Oncol 1998; 9: 691-693.
    • (1998) Ann. Oncol. , vol.9 , pp. 691-693
    • Green, M.1
  • 5
    • 0028989408 scopus 로고
    • Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer
    • Lipschultz S, Lipsitz S, Mone S et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. New Engl J Med 1995; 332: 1738-1743.
    • (1995) New Engl. J. Med. , vol.332 , pp. 1738-1743
    • Lipschultz, S.1    Lipsitz, S.2    Mone, S.3
  • 6
    • 0035155497 scopus 로고    scopus 로고
    • Anthracycline-induced clinical heart failure in a cohort of 607 children: Long term follow-up study
    • Kremer L, Van Dalen E, Offringa M et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long term follow-up study. J Clin Oncol 2001; 19: 191-196.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 191-196
    • Kremer, L.1    Van Dalen, E.2    Offringa, M.3
  • 7
    • 0034643399 scopus 로고    scopus 로고
    • Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy
    • Felker M, Thompson R, Hare J et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
    • (2000) N. Engl. J. Med. , vol.342 , pp. 1077-1084
    • Felker, M.1    Thompson, R.2    Hare, J.3
  • 8
    • 0030904457 scopus 로고    scopus 로고
    • Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience
    • Krisher J, Epstein S, Cuthbertson D et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 1997; 15: 1544-1552.
    • (1997) J. Clin. Oncol. , vol.15 , pp. 1544-1552
    • Krisher, J.1    Epstein, S.2    Cuthbertson, D.3
  • 9
    • 0026031848 scopus 로고
    • Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
    • Lipschultz S, Colan S, Gelber R et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 324: 808-815.
    • (1991) N. Engl. J. Med. , vol.324 , pp. 808-815
    • Lipschultz, S.1    Colan, S.2    Gelber, R.3
  • 10
    • 0025850827 scopus 로고
    • Cardiac toxicity 4 to 20 years after completing anthracycline therapy
    • Steinherz L, Steinherz P, Tan C et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.
    • (1991) JAMA , vol.266 , pp. 1672-1677
    • Steinherz, L.1    Steinherz, P.2    Tan, C.3
  • 11
    • 0031017043 scopus 로고    scopus 로고
    • Anthracycline dose in childhood acute lymphoblastic leukemia: Issues of early survival versus late cardiotoxicity
    • Sorensen K, Levitt G, Bull C et al. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. J Clin Oncol 1997; 15: 61-68.
    • (1997) J. Clin. Oncol. , vol.15 , pp. 61-68
    • Sorensen, K.1    Levitt, G.2    Bull, C.3
  • 12
    • 0030904096 scopus 로고    scopus 로고
    • Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
    • Swain S, Whaley F, Gerber M et al. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol 1997; 15: 1318-1332.
    • (1997) J. Clin. Oncol. , vol.15 , pp. 1318-1332
    • Swain, S.1    Whaley, F.2    Gerber, M.3
  • 13
    • 0035282073 scopus 로고    scopus 로고
    • Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer
    • Batist G, Ramakrishnan G, Sekhar Rao C et al. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer. J Clin Oncol 2001; 19: 1444-1454.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 1444-1454
    • Batist, G.1    Ramakrishnan, G.2    Sekhar Rao, C.3
  • 14
    • 0035125066 scopus 로고    scopus 로고
    • Survival in patients with intermediate or high-grade non-Hodgkin's lymphoma: Meta-analysis of randomized studies comparing third generation regimens with CHOP
    • Messori A, Vaiani M, Trippoli S. Survival in patients with intermediate or high-grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP. Br J Cancer 2001; 84: 303-307.
    • (2001) Br. J. Cancer , vol.84 , pp. 303-307
    • Messori, A.1    Vaiani, M.2    Trippoli, S.3
  • 15
    • 0031801499 scopus 로고    scopus 로고
    • Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas
    • Haddy T, Adde M, McCalla J et al. Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas. J Clin Oncol 1998; 16: 2070-2079.
    • (1998) J. Clin. Oncol. , vol.16 , pp. 2070-2079
    • Haddy, T.1    Adde, M.2    McCalla, J.3
  • 16
    • 0018757883 scopus 로고
    • Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography
    • Alexander J, Dainiak N, Berger H et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 1979; 300: 278-283.
    • (1979) N. Engl. J. Med. , vol.300 , pp. 278-283
    • Alexander, J.1    Dainiak, N.2    Berger, H.3
  • 17
    • 0023634395 scopus 로고
    • Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography
    • Schwartz R, McKenzie W, Alexander J et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 1987; 82: 1109-1118.
    • (1987) Am. J. Med. , vol.82 , pp. 1109-1118
    • Schwartz, R.1    McKenzie, W.2    Alexander, J.3
  • 18
    • 0020038042 scopus 로고
    • Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
    • Legha S, Benjamin R, Mackay B et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 1982; 96: 133-139.
    • (1982) Ann. Intern. Med. , vol.96 , pp. 133-139
    • Legha, S.1    Benjamin, R.2    Mackay, B.3
  • 19
    • 0032921354 scopus 로고    scopus 로고
    • Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: Autonomic versus echocardiographic variables
    • Tjeerdsma G, Meinardi M, Van der Graf W et al. Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables. Heart 1999; 81: 419-423.
    • (1999) Heart , vol.81 , pp. 419-423
    • Tjeerdsma, G.1    Meinardi, M.2    Van der Graf, W.3
  • 20
    • 0032983504 scopus 로고    scopus 로고
    • Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin
    • Herman E, Zhang J, Lipschultz E et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 1999; 17: 2237-2243.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 2237-2243
    • Herman, E.1    Zhang, J.2    Lipschultz, E.3
  • 21
    • 0030882421 scopus 로고    scopus 로고
    • Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
    • McDonagh T, Morrison C, Lawrence A et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-833.
    • (1997) Lancet , vol.350 , pp. 829-833
    • McDonagh, T.1    Morrison, C.2    Lawrence, A.3
  • 22
    • 0035845307 scopus 로고    scopus 로고
    • Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: A population based study
    • Davies M, Hobbs F, Davis R et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population based study. Lancet 2001; 358: 439-444.
    • (2001) Lancet , vol.358 , pp. 439-444
    • Davies, M.1    Hobbs, F.2    Davis, R.3
  • 23
    • 0032872127 scopus 로고    scopus 로고
    • American, Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants
    • Hensley M, Schuchter L, Lindley C et al. American, Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999; 17: 3333-3355.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 3333-3355
    • Hensley, M.1    Schuchter, L.2    Lindley, C.3
  • 24
    • 0004815869 scopus 로고    scopus 로고
    • CHOP is the standard regimen in patients ≥70 years of age with intermediate grade or high grade non-Hodgkin's lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
    • Tirelli U, Errante D, Van Glabbeke M et al. CHOP is the standard regimen in patients ≥70 years of age with intermediate grade or high grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998; 16: 27-34.
    • (1998) J. Clin. Oncol. , vol.16 , pp. 27-34
    • Tirelli, U.1    Errante, D.2    Van Glabbeke, M.3
  • 25
    • 0037165261 scopus 로고    scopus 로고
    • CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
    • Coiffier B, Lepage E, Brière, J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New Engl J Med 2002; 346: 235-242.
    • (2002) New Engl. J. Med. , vol.346 , pp. 235-242
    • Coiffier, B.1    Lepage, E.2    Brière, J.3
  • 26
    • 0032100459 scopus 로고    scopus 로고
    • A randomized comparison of the efficacity and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma
    • Nair R, Ramakrishnan G, Nair N et al. A randomized comparison of the efficacity and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma. Cancer 1998; 82: 2282-2288.
    • (1998) Cancer , vol.82 , pp. 2282-2288
    • Nair, R.1    Ramakrishnan, G.2    Nair, N.3
  • 27
    • 0031698016 scopus 로고    scopus 로고
    • Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy
    • Phillips K, Tannock I. Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. J Clin Oncol 1998; 16: 3179-3190.
    • (1998) J. Clin. Oncol. , vol.16 , pp. 3179-3190
    • Phillips, K.1    Tannock, I.2
  • 28
    • 0032951328 scopus 로고    scopus 로고
    • International consensus conference on high dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphoma: Report of the jury
    • Shipp M, Abeloff M, Antman K et al. International consensus conference on high dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphoma: report of the jury. J Clin Oncol 1999; 17: 423-429.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 423-429
    • Shipp, M.1    Abeloff, M.2    Antman, K.3
  • 29
    • 0033890745 scopus 로고    scopus 로고
    • Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH-87 protocol-a Groupe d'Etude des Lymphomes de l'Adulte study
    • Haioun C, Lepage E, Gisselbrecht C et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH-87 protocol-a Groupe d'Etude des Lymphomes de l'Adulte study. J Clin Oncol 2000; 18: 3025-3030.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 3025-3030
    • Haioun, C.1    Lepage, E.2    Gisselbrecht, C.3
  • 30
    • 17744376759 scopus 로고    scopus 로고
    • Severe toxicity in hematological stem cell transplantation: Predictive value of reduced left ventricular ejection fraction
    • Fujimaki K, Maruta A, Yoshida M et al. Severe toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001; 27: 307-310.
    • (2001) Bone Marrow Transplant. , vol.27 , pp. 307-310
    • Fujimaki, K.1    Maruta, A.2    Yoshida, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.